Cite
HARVARD Citation
Yilmaz, M. et al. (2021). FLT3 inhibitor based induction and allogeneic stem cell transplant in complete remission 1 improve outcomes in patients with newly diagnosed Acute Myeloid Leukemia with very low FLT3 allelic burden. American journal of hematology. 96 (8), pp. E275-E279. [Online].